BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8962347)

  • 1. Results of kidney transplantation in HBsAG and anti-HCV seropositive renal allograft recipients.
    Durlik M; Gaciong Z; Soluch L; Rowińska D; Kozłowska-Boszko B; Rowiński W; Szmidt J; Lao M
    Transplant Proc; 1996 Dec; 28(6):3459-60. PubMed ID: 8962347
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical outcome of anti-HCV(+) renal allograft recipients.
    Lee SW; Kang SW; Choi KH; Han KH; Lee HY; Han DS; Kim YS; Park K
    Transplant Proc; 1996 Jun; 28(3):1501-2. PubMed ID: 8658759
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk of chronic liver disease in HBsAG and/or anti-HCV-positive renal allograft recipients.
    Durlik M; Gaciong Z; Soluch L; Walecka-Zielecka B; Rancewicz Z; Rowińska D; Rowiński W; Szmidt J; Lao M
    Transplant Proc; 1996 Feb; 28(1):50-1. PubMed ID: 8644327
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of donor hepatitis B antigenemia on renal allograft in hepatitis B recipients.
    Chen JB; Hsieh H; Hsu KT; Chen CH
    Transplant Proc; 1996 Jun; 28(3):1490-2. PubMed ID: 8658755
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical outcome of HBsAg(+) renal allograft recipients.
    Kang SW; Lee SW; Choi KH; Han KH; Lee HY; Han DS; Kim YS; Park K
    Transplant Proc; 1996 Jun; 28(3):1653-4. PubMed ID: 8658823
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of hepatitis B and C virus infection on the outcome of kidney transplantation in Chinese patients.
    Huo TI; Yang WC; Wu JC; King KL; Loong CC; Lin CY; Lui WY; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):93-100. PubMed ID: 10677918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of hepatitis B and C virus on kidney transplantation outcome.
    Mathurin P; Mouquet C; Poynard T; Sylla C; Benalia H; Fretz C; Thibault V; Cadranel JF; Bernard B; Opolon P; Coriat P; Bitker MO
    Hepatology; 1999 Jan; 29(1):257-63. PubMed ID: 9862875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different impacts of hepatitis B virus and hepatitis C virus on the outcome of kidney transplantation.
    Ingsathit A; Thakkinstian A; Kantachuvesiri S; Sumethkul V
    Transplant Proc; 2007 Jun; 39(5):1424-8. PubMed ID: 17580153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of hepatitis B and hepatitis C virus infection on the outcome of kidney transplantation.
    Yuan CH; Liu YF; Li GC
    Chin Med Sci J; 2005 Jun; 20(2):129-32. PubMed ID: 16075755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of presence of HBs antigen and anti-hepatitis C virus and anti-cytomegalovirus antibodies on transplanted kidney survival.
    Sieńko J; Wiśniewska M; Ciechanowski K; Rózański J; Domański L; Myslak M; Kamiński M; Sulikowski T; Pabisiak K; Romanowski M; Mizerski A; Tejchman K; Nowacki M; Ostrowski M; Bohatyrewicz R
    Transplant Proc; 2006; 38(1):136-8. PubMed ID: 16504685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hepatitis B and C virus infections on kidney transplantation: a single center experience.
    Santos L; Alves R; Macario F; Parada B; Campos M; Mota A
    Transplant Proc; 2009 Apr; 41(3):880-2. PubMed ID: 19376378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors.
    Sumethkul V; Ingsathit A; Jirasiritham S
    Transplant Proc; 2009; 41(1):213-5. PubMed ID: 19249516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBsAg as predictor of outcome in renal transplant patients.
    Ridruejo E; Brunet Mdel R; Cusumano A; Diaz C; Michel MD; Jost L; Jost L; Mando OG; Vilches A
    Medicina (B Aires); 2004; 64(5):429-32. PubMed ID: 15560544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney transplantation from hepatitis B surface antigen (HBsAg)-positive donors: changes of relative HBV genomic copy number after transplantation.
    Lai MK; Chang KS; Chueh SC; Huang CC; Chen SC; Chu SH
    Transplant Proc; 1996 Jun; 28(3):1518-9. PubMed ID: 8658767
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of HCV infection on first cadaveric renal transplantation, a single center experience.
    Lin HH; Huang CC; Huang JY; Yang CW; Wu MS; Fang JT; Yu CC; Chiang YJ; Chu SH
    Clin Transplant; 2004 Jun; 18(3):261-6. PubMed ID: 15142046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of hepatitis B and hepatitis C virus infections on patients and allograft outcomes in renal transplant recipients: a single center study.
    Ghafari A; Sanadgol H
    Transplant Proc; 2008; 40(1):196-8. PubMed ID: 18261585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of serum antibodies to hepatitis B and C viruses in patients with primary glomerulonephritis.
    Altiparmak MR; Pamuk ON; Pamuk GE; Mert A; Ataman R; Serdengeçti K
    J Nephrol; 2001; 14(5):388-91. PubMed ID: 11730272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C in kidney transplant patients.
    Oka T; Yasumura T
    Transplant Proc; 1996 Jun; 28(3):1163-7. PubMed ID: 8658612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.